This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| SATT Ouest Valorisation | |
|---|---|
| Name | SATT Ouest Valorisation |
| Type | Private technology transfer company |
| Founded | 2012 |
| Headquarters | Rennes, Nantes |
| Area served | Brittany, Pays de la Loire, Normandy |
| Industry | Technology transfer, research commercialization |
SATT Ouest Valorisation is a French technology transfer company created to accelerate the maturation and valorization of research from public laboratories into commercially viable products and startups. It operates within the French SATT network alongside regional actors and national institutions to bridge gaps between academic research and private investment. The company engages with universities, research organizations, hospitals, and firms to manage intellectual property, prototype development, and licensing.
SATT Ouest Valorisation was established in 2012 following reforms associated with the Investissements d'Avenir program and coordination between regional stakeholders such as Région Bretagne, Région Pays de la Loire, and higher education actors like Université de Rennes 1, Université de Nantes, Université de Rennes 2, CNRS, and Inserm. Its creation paralleled the founding of other SATTs including SATT Lutech, SATT AxLR, and SATT Grand Centre, and responded to national discussions involving the Ministry of Higher Education, Research and Innovation, the Commissariat général à l'investissement, and the Agence Nationale de la Recherche. Early activity linked teams from research-intensive institutions such as INRIA, CEA, and regional hospitals including CHU de Nantes and CHU de Rennes to development programs inspired by European innovation frameworks like Horizon 2020.
The governance structure brings together representatives from founding institutions: universities (for example Université de Bretagne Occidentale), national research organizations (CNRS, Inserm, INRAE), and regional authorities (Pays de la Loire, Brittany). A board of directors includes appointees from actors such as Région Normandie and partner companies similar to Eurazeo or Bpifrance in the broader French innovation ecosystem. Executive management interfaces with technology scouts, project managers, and intellectual property specialists, interacting with entities like European Investment Bank-linked programs and legal frameworks such as the Code de la propriété intellectuelle to align commercialization strategies.
SATT Ouest Valorisation's mission centers on transferring inventions from laboratories into markets by protecting inventions, funding proof-of-concept projects, and creating startups. Activities include patent filing and portfolio management with links to actors like INPI, supporting prototype work often in coordination with CNRS Laboratories and clinical partners such as CHU de Rennes, and providing acceleration services similar to those offered by incubators like Paris Saclay Incubation or Euratechnologies. The company also develops licensing strategies, equity investments in spin-offs, and organizes events akin to VivaTech or regional innovation forums.
Technology transfer processes involve evaluation of disclosure from researchers affiliated with institutions such as Université de Nantes or Institut Curie-style research centers, assessment against market benchmarks including comparisons with startups from Station F, and collaboration with venture investors similar to Seventure Partners or corporate venture arms like Sanofi Ventures. Commercialization pathways include exclusive licensing to industrial partners such as Bayer, AstraZeneca, or SMEs in Brittany, and the formation of spin-offs with business model support resembling programs at INSEAD or HEC Paris for entrepreneurship.
Key projects span biotechnology, medical devices, digital health, materials science, and green chemistry. Examples include translational programs stemming from teams in Inserm Unit projects, medical imaging advances related to researchers associated with CEA NeuroSpin-type facilities, and software tools derived from collaborations with INRIA groups. Innovations have targeted sectors represented by companies like Ipsen in biopharma, renewable energy initiatives comparable to EDF Renewables, and agritech developments connected to INRAE research.
SATT Ouest Valorisation partners with universities and research centers including Université de Rennes 1, Université de Nantes, CNRS, Inserm, INRAE, and INRIA, as well as hospitals such as CHU de Rennes and CHU de Nantes. It collaborates with regional authorities like Région Bretagne and economic development agencies, and engages with investors and accelerators comparable to Bpifrance, EuraTechnologies, and Lyon Start Up. International links include participation in Horizon Europe projects and connections to European networks such as EIT Health and bilateral cooperation with institutions like Imperial College London or Karolinska Institutet through research consortia.
Impact is measured by indicators common in technology transfer: number of invention disclosures, patent families filed with INPI and international offices, licenses executed, startups created, jobs supported, and follow-on funding attracted from sources like Bpifrance and private venture capital. Regional economic reports benchmark performance against other SATTs and against metrics from organizations such as Observatoire des SATT. Outcomes include spin-offs that attract seed and Series A financing, licensing deals with industry partners, and contributions to regional innovation clusters comparable to French Tech hubs.
Category:Technology transfer organizations Category:Research and development in France